Open CarolineMorton opened 4 years ago
Psoriasis: https://datacompass.lshtm.ac.uk/1255/
@CarolineMorton
Just to confirm, I assume autoimmune disorders are being assessed as a risk factor for severe COVID19?
As there are many autoimmune disorders, I wondered if a decision had been made to only include SLE and psoriasis? Is there a rationale for choosing these? What about others, such as Coeliac disease, Inflammatory bowel disease, MS, ulcerative colitis, Guillain-Barre syndrome, Addison’s etc?
These are the code lists that @hmcd has provided. If possible, we would want more autoimmune diseases, although not IBD, Addisons, GBS or MS (as they are included elsewhere) in IBD, Endocrine, and Neurological code lists. Coeliac would be good to include.
Here's a broad list of autoimmune conditions. There's possibly too many, I suppose it depends how broad we want to go and if we really think they'll be at greater risk of severe Covid?
As mentioned above, some fall into other code lists. I have made a column for those to include (Y-Yes, N-No), with an explanation for the No's. @CarolineMorton and @hmcd
Hi @hjforbes
I will defer to @hmcd for her opinion on this. I suspect we could have a never ending list of auto immune conditions and we probably only want to catch the big ones, otherwise where do you stop?
What do you suggest @hmcd?
@hjforbes Just having a chat with @hmcd
We are going to initially go for a common autoimmune group that includes:
I have done RA already as included with OA. Would you be able to look at Psoriasis / SLE code lists? We may come back to the longer code lists (for example, vasculitis) at a later date.
Sure, on it
DEFINITION: Current, or any history of, autoimmune disorders (specifically SLE and psoriasis). As mentioned above this can get expanded to other autoimmune conditions in the future if required.
STEP 1: Read codes version 2 autoimmune_v1.xlsx
STEP 2: QOF (only lupus features in QOF) qof-autoimmune.xlsx
STEP 3: SNOMED cluster snomed-autoimmune.xlsx
Further thought @CarolineMorton, should we identify patients with autoimmune conditions currently taking immunosupressants (say a prescription for an immune suppressant within the last three months), and patients with autoimmune conditions not on immunosuppressants? We could look at prescription dose, but that may be a step too far at this stage.
This will help us with the questions:
Summary of discussion on phone call from 8-4-2020 with Liam, Ben, Krishnan, @hmcd, Laurie, @alexwalkercebm, @SJWEvans, @StatsFizz, @annaschultze
Plan not to include all autoimmune conditions but to choose large patient populations of patients with autoimmune disease who are not currently in shielding criteria. If positive association found, then may want to do a further study just looking at autoimmunity.
I have renamed this to reflect this.
DRAFT SIGN OFF
DEFINITION: Patients who have any Read 3 code for Rheumatoid Arthritis or SLE or Psoriasis ever on their medical records held by TPP. Absence of a code on the record is taken as no presence of disease.
Example output: | patient_id | condition | date |
---|---|---|---|
123 | Rheumatoid Arthritis | 1/2/2009 | |
332 | SLE | 2/4/2016 |
CODE LISTS: Read 3 code list - FINAL code list: ra-sle-psoriasis-final.xlsx
Created using this method by TPP:
Read 2 LSHTM validated code list:
Adding in key clusters from QOF and mapping to CTV3
Adding in high level snowmed codes and mapping to CTV3. Key Terms searched for in CT SNOWMED BROWSER:
_Final list sense checked
(see discussion from ebmdatalab/tpp-sql-notebook#19 on RA codes)
Caroline and I discussed over slack we should include RA monitoring invite codes, as patients must have RA to be on a monitoring list, and may help capture the less compliant of the RA patients.
POTENTIAL BIASES: We may be missing people who are solely managed in secondary care, perhaps the most severe cases or newly diagnosed.
CLINICAL SIGN OFF & DATE:
EPIDEMIOLOGY SIGN OFF & DATE:
SHARED WITH WIDER TEAM: Yes
FINAL SIGN OFF DATE (and apply label)
@laurietomlinson @CarolineMorton
Few queries from this code list
“Localised pustular psoriasis” was excluded from original Read lists, on assumption it doesn’t have a systemic effect (non-specific pustular psoriasis and generalised pustular psoriasis were included). Happy for me to therefore exclude it?
I’m also wondering if “Generalised pustular psoriasis of pregnancy” should be in? Isn’t this transient and likely to resolve after pregnancy?
Limited lupus erythematosus – possibly exclude, as again, local rather than generalised?
Neonatal lupus erythematosus – we had excluded these, on the basis it was unlikely to be relevant to the population, but now I suggest including for thoroughness.
[Bullous impetigo] or [impetigo herpetiformis] – exclude, as it could be impetigo?
Hi Harriet, Yes this all sounds reasonable. thank you for spotting. Woudlyou be able to change and reupload? You should be able to copy the sign off above into a comment below, with the new documents.
thank you!
@hjforbes Hi Harriet. My view was that even the localised disease showed an underlying autoimmune predisposition. Given the accuracy of coding, and now that I understand the purpose of the code list, my thought was better to capture more patients rather than being specific. Agree re pregnancy, though I think the 'predisposition' argument still holds. Thanks a lot
Probably either way will be ok. @laurietomlinson you certainly know more about this than me so happy to go with your suggestion.
@laurietomlinson @CarolineMorton Thanks! Ah, I thought it was less predisposition to autoimmune disorders, and more an actual autoimmune disorder we were trying to capture.
if that is correct, I think the following makes sense, but feel free to re-jig if I'm wrong
Include
Exclude
@laurietomlinson okay so following that call with Ian, I see your point about predisposition! Sorry. So, I think we want to following:
Include Neonatal lupus erythematosus “Generalised pustular psoriasis of pregnancy” localised PS and SLE
Exclude [Bullous impetigo] or [impetigo herpetiformis]
If yes, I will revise the final code list now
@hjforbes ha funny I was going to say that the point about localised OA capturing generalised OA was what I meant but you'd already got it. Sounds good to me? Glad you are all settled in Bristol, it looks lovely
Copy.of.Autoimmune_CTV3_LT_HF.xlsx
Final list! Only 1 change, as described above.
Hi Harriet,
Do you think you could combine your RA and SLE/Psoriasis code lists into one and upload here?
Then I do the final sign off. thank you
I have removed the codes we don't want included, to avoid any confusion.
FINAL SIGN OFF
DEFINITION: Patients who have any Read 3 code for Rheumatoid Arthritis or SLE or Psoriasis ever on their medical records held by TPP. Absence of a code on the record is taken as no presence of disease.
Example output: | patient_id | date |
---|---|---|
123 | 1/2/2009 | |
332 | 2/4/2016 |
CODE LISTS: Read 3 code list - FINAL code list: FINAL_RA_PSOR_SLE.xlsx
Created using this method by TPP:
Read 2 LSHTM validated code list:
Adding in key clusters from QOF and mapping to CTV3
Adding in high level snowmed codes and mapping to CTV3. Key Terms searched for in CT SNOWMED BROWSER:
_Final list sense checked
(see discussion from ebmdatalab/tpp-sql-notebook#19 on RA codes)
Caroline and I discussed over slack we should include RA monitoring invite codes, as patients must have RA to be on a monitoring list, and may help capture the less compliant of the RA patients.
POTENTIAL BIASES: We may be missing people who are solely managed in secondary care, perhaps the most severe cases or newly diagnosed.
CLINICAL SIGN OFF & DATE: Caroline Morton @CarolineMorton 10-4-2020
EPIDEMIOLOGY SIGN OFF & DATE: Laurie Tomlinson @laurietomlinson 14-4-2020
SHARED WITH WIDER TEAM: Yes
FINAL SIGN OFF DATE (and apply label) 14-4-2020 09:44
SLE: From LSHTM: https://datacompass.lshtm.ac.uk/356/
Need to write a definition. @hmcd do you have this easily accessible and could you write below if you do. It is a definition in plain english of what the codes are.